Debanjana Chatterjee
Stock Analyst at Jones Trading
(3.69)
# 728
Out of 5,129 analysts
14
Total ratings
83.33%
Success rate
20.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARMP Armata Pharmaceuticals | Initiates: Buy | $15 | $8.00 | +87.50% | 1 | Jan 5, 2026 | |
| SYRE Spyre Therapeutics | Upgrades: Buy | $64 | $33.92 | +88.68% | 2 | Dec 1, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Hold | n/a | $12.00 | - | 2 | Nov 11, 2025 | |
| SION Sionna Therapeutics | Initiates: Buy | $46 | $36.53 | +25.92% | 1 | Sep 8, 2025 | |
| TBPH Theravance Biopharma | Initiates: Buy | $24 | $19.51 | +23.01% | 1 | Jun 17, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Buy | $15 → $27 | $5.25 | +414.29% | 2 | Jun 6, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Buy | $39 | $3.79 | +929.02% | 1 | Apr 28, 2025 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $30 | $15.51 | +93.42% | 2 | Mar 26, 2025 | |
| CTNM Contineum Therapeutics | Initiates: Buy | $23 | $15.26 | +50.72% | 1 | Mar 13, 2025 | |
| PHVS Pharvaris | Initiates: Buy | $46 | $27.31 | +68.44% | 1 | Sep 19, 2024 |
Armata Pharmaceuticals
Jan 5, 2026
Initiates: Buy
Price Target: $15
Current: $8.00
Upside: +87.50%
Spyre Therapeutics
Dec 1, 2025
Upgrades: Buy
Price Target: $64
Current: $33.92
Upside: +88.68%
Intellia Therapeutics
Nov 11, 2025
Downgrades: Hold
Price Target: n/a
Current: $12.00
Upside: -
Sionna Therapeutics
Sep 8, 2025
Initiates: Buy
Price Target: $46
Current: $36.53
Upside: +25.92%
Theravance Biopharma
Jun 17, 2025
Initiates: Buy
Price Target: $24
Current: $19.51
Upside: +23.01%
Sagimet Biosciences
Jun 6, 2025
Maintains: Buy
Price Target: $15 → $27
Current: $5.25
Upside: +414.29%
Tvardi Therapeutics
Apr 28, 2025
Initiates: Buy
Price Target: $39
Current: $3.79
Upside: +929.02%
KalVista Pharmaceuticals
Mar 26, 2025
Maintains: Buy
Price Target: $30
Current: $15.51
Upside: +93.42%
Contineum Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $23
Current: $15.26
Upside: +50.72%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $27.31
Upside: +68.44%